Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$693K Buy
26,600
+9,600
+56% +$291K ﹤0.01% 4277
2026
Q1
$474K Sell
17,000
-2,400
-12% -$61.1K ﹤0.01% 4094
2025
Q4
$380K Buy
19,400
+6,600
+52% +$139K ﹤0.01% 3652
2025
Q3
$264K Sell
12,800
-200
-2% -$4.03K ﹤0.01% 3463
2025
Q2
$217K Buy
+13,000
New +$217K ﹤0.01% 3234

Other funds holding TRMD

IMC Chicago's TRMD Position: Q2 2026 in Review

IMC Chicago increased its TORM (TRMD) stake by 40% in Q2 2026, buying an estimated $218K and bringing the position to 25,275 shares worth $659K. The position accounts for ﹤0.01% of the portfolio, ranked #4327.

IMC Chicago first reported a position in TRMD in Q3 2024 and has held it in 4 quarters since. 152 funds tracked by Wall St. Rank hold TRMD as of Q2 2026.

  • IMC Chicago held 25,275 shares of TORM worth $659K as of Q2 2026.
  • IMC Chicago bought 7,196 TORM shares in Q2 2026, an estimated $218K.
  • TORM made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4327 holding.
  • IMC Chicago first reported a position in TORM in Q3 2024 and has held it in 4 quarters since.
  • 152 funds tracked by Wall St. Rank held TORM as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.